Bioorganic & Medicinal Chemistry Letters 2012-03-01

Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.

Jianwei Yan, Ning Huang, Shukun Li, Liu-Meng Yang, Weiqiang Xing, Yong-Tang Zheng, Youhong Hu

Index: Bioorg. Med. Chem. Lett. 5th ed., 22 , 1976-1979, (2012)

Full Text: HTML

Abstract

A series of P1-substituted biaryl amprenavir derivatives was designed and synthesized. These compounds were evaluated for enzyme inhibition and antiviral activity in vitro. Several compounds showed highly efficient antiviral activity with EC(50) values down to 0.10nM, which are more potent than marketed HIV-1 protease inhibitors. Docking study indicated that 12c has similar binding mode to amprenavir with full occupancy in P1.Copyright © 2012 Elsevier Ltd. All rights reserved.

Related Compounds

  • Amprenavir
  • Pyridine-4-boronic...
  • 3-Pyridylboronic a...

Related Articles:

A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.

2014-12-01

[Eur. J. Drug Metab. Pharmacokinet. 39(4) , 263-76, (2014)]

Parallel ultra high pressure liquid chromatography-mass spectrometry for the quantification of HIV protease inhibitors using dried spot sample collection format.

2014-08-15

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 965 , 244-53, (2014)]

HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.

2015-01-01

[PLoS ONE 10(2) , e0116886, (2015)]

Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran.

2013-05-23

[J. Med. Chem. 56(10) , 4017-27, (2013)]

Suppression of pre adipocyte differentiation and promotion of adipocyte death by anti-HIV drugs.

2012-01-01

[In Vivo 26(2) , 287-91, (2012)]

More Articles...